Picture of Gensight Biologics SA logo

SIGHT — Gensight Biologics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Gensight Biologics SA Says Taking Additional Measures To Reduce Operating Cash Burn In 2023

April 20 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS SA - CURRENT CASH RUNWAY TO JUNE 2023
    * GENSIGHT BIOLOGICS SA - THREE PPQ BATCHES COULD BE
RELEASED FOR
HUMAN USE BY END OF YEAR
    * GENSIGHT BIOLOGICS SA - CURRENTLY REVIEWING IMPACT OF
CURRENT
SITUATION ON EXISTING FINANCING
    * GENSIGHT BIOLOGICS SA- CURRENT CASH RUNWAY TO JUNE 2023;
ADVANCED DISCUSSIONS ON FINANCING AND STRATEGIC OPTIONS
INCLUDING M&A ONGOING
    * GENSIGHT BIOLOGICS SA - TAKING ADDITIONAL MEASURES AIMED
AT
SIGNIFICANTLY REDUCING ITS OPERATING CASH BURN IN 2023
    * GENSIGHT BIOLOGICS SA - EXPECTS TO INITIATE VALIDATION
CAMPAIGN
IN MAY 2023, WITH RESULTS EXPECTED IN Q3 2023

Source text for Eikon:  ID:nBw4bmbjma 
Further company coverage:  SIGHT.PA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Gensight Biologics SA

See all news